smithkline skb boehringer finalize pact smithkline beckman boehringer mannheim gmbh sign final agreement develop market cardiovascular medicine discover boehringer agreement smithkline responsibility develop product partner market product abroad initially smithkline company concentrate clinical development market carvedilol compound treat mild moderate hypertension angina application market approval carvedilol submit germany december smithkline application expect european market submission food drug administration project underway thromboxane receptor antagonist compound useful accelerate disolution blood clot prevent blod clot occur heart attack arterial disease company compound clinical evaluation europe 
